Literature DB >> 10337014

Cytokine-producing cells in peripheral blood of children with coeliac disease secrete cytokines with a type 1 profile.

T Hansson1, A Dannaeus, L Klareskog.   

Abstract

Coeliac disease (CoD) is a small intestinal disorder characterized by crypt cell hyperplasia and villous atrophy, and the production of cytokines from T cells and macrophages are of importance for the histological changes seen in CoD. A peroral immunization with an antigen, which gives rise to a mucosal immune response, may increase the levels of circulating cytokine-producing cells, and we wanted to obtain a better picture of an eventual emergence of activated circulating T cells in the peripheral blood in children with CoD. The cytokine expression of interferon-gamma (IFN-gamma), IL-4, IL-6 and IL-10 was measured at the single-cell level by an ELISPOT method in 38 children with CoD. The numbers of IFN-gamma-producing cells in the peripheral blood was increased in children with untreated CoD (P < 0.01) and after gluten challenge (P < 0.05) compared with healthy controls. Also, the numbers of IL-6-producing cells were increased (P < 0.05) after gluten challenge compared with the healthy controls. A paired comparison showed that the numbers of IFN-gamma-producing cells increased after gluten challenge (P < 0.05), whereas no such change was seen for IL-4- or IL-10-producing cells. There were no differences in the numbers of IFN-gamma-producing cells between the group of children with treated CoD and the groups of untreated or challenged CoD children. IL-4 production correlated with serum levels of total IgE. These results show that circulating mononuclear cells in children with active CoD secrete cytokines compatible with a type 1 response.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10337014      PMCID: PMC1905277          DOI: 10.1046/j.1365-2249.1999.00882.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  20 in total

1.  Immunohistochemical analysis of mucosal gamma-interferon production in coeliac disease.

Authors:  A al-Dawoud; I Nakshabendi; A Foulis; A M Mowat
Journal:  Gut       Date:  1992-11       Impact factor: 23.059

Review 2.  TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties.

Authors:  T R Mosmann; R L Coffman
Journal:  Annu Rev Immunol       Date:  1989       Impact factor: 28.527

Review 3.  Gluten, major histocompatibility complex, and the small intestine. A molecular and immunobiologic approach to the spectrum of gluten sensitivity ('celiac sprue').

Authors:  M N Marsh
Journal:  Gastroenterology       Date:  1992-01       Impact factor: 22.682

4.  Tissue transglutaminase selectively modifies gliadin peptides that are recognized by gut-derived T cells in celiac disease.

Authors:  O Molberg; S N Mcadam; R Körner; H Quarsten; C Kristiansen; L Madsen; L Fugger; H Scott; O Norén; P Roepstorff; K E Lundin; H Sjöström; L M Sollid
Journal:  Nat Med       Date:  1998-06       Impact factor: 53.440

5.  Reduced interferon-gamma (IFN-gamma) secretion with increased IFN-gamma mRNA expression in atopic dermatitis: evidence for a post-transcriptional defect.

Authors:  M L Tang; G Varigos; A S Kemp
Journal:  Clin Exp Immunol       Date:  1994-09       Impact factor: 4.330

6.  Detection of interferon gamma mRNA in the mucosa of patients with coeliac disease by in situ hybridisation.

Authors:  M Kontakou; R P Sturgess; R T Przemioslo; G A Limb; J M Nelufer; P J Ciclitira
Journal:  Gut       Date:  1994-08       Impact factor: 23.059

7.  Cytokine mRNA expression in the mucosa of treated coeliac patients after wheat peptide challenge.

Authors:  M Kontakou; R T Przemioslo; R P Sturgess; G A Limb; H J Ellis; P Day; P J Ciclitira
Journal:  Gut       Date:  1995-07       Impact factor: 23.059

8.  Raised pro-inflammatory cytokines interleukin 6 and tumour necrosis factor alpha in coeliac disease mucosa detected by immunohistochemistry.

Authors:  R T Przemioslo; M Kontakou; V Nobili; P J Ciclitira
Journal:  Gut       Date:  1994-10       Impact factor: 23.059

9.  Expression of tumour necrosis factor-alpha, interleukin-6, and interleukin-2 mRNA in the jejunum of patients with coeliac disease.

Authors:  M Kontakou; R T Przemioslo; R P Sturgess; A G Limb; P J Ciclitira
Journal:  Scand J Gastroenterol       Date:  1995-05       Impact factor: 2.423

10.  Evidence that activated mucosal T cells play a role in the pathogenesis of enteropathy in human small intestine.

Authors:  T T MacDonald; J Spencer
Journal:  J Exp Med       Date:  1988-04-01       Impact factor: 14.307

View more
  9 in total

1.  Co-occurrence of IgA antibodies against ethanol metabolites and tissue transglutaminase in alcohol consumers: correlation with proinflammatory cytokines and markers of fibrogenesis.

Authors:  Heidi Koivisto; Johanna Hietala; Petra Anttila; Onni Niemelä
Journal:  Dig Dis Sci       Date:  2007-06-28       Impact factor: 3.199

2.  Naturally occurring and inducible T-regulatory cells modulating immune response in allergic asthma.

Authors:  Halvor S McGee; Devendra K Agrawal
Journal:  Am J Respir Crit Care Med       Date:  2009-05-15       Impact factor: 21.405

3.  The chemokine CCL28 is elevated in the serum of patients with celiac disease and decreased after treatment.

Authors:  Shima Rashidiani; Ali Jalili; Erfan Babaei; Farsad Sheikhesmaeili; Shohreh Fakhari; Pedram Ataee; Baran Parhizkar
Journal:  Am J Clin Exp Immunol       Date:  2017-06-15

4.  Enhanced interleukin-18 levels in the peripheral blood of children with coeliac disease.

Authors:  H Lettesjö; T Hansson; A Bergqvist; J Grönlund; A Dannaeus
Journal:  Clin Exp Immunol       Date:  2005-01       Impact factor: 4.330

5.  Serum soluble interleukin-2 receptor, interleukin-6 and tumor necrosis factor alpha as markers of celiac disease activity.

Authors:  Akshay Kapoor; A K Patwari; Praveen Kumar; Anju Jain; Shashi Narayan
Journal:  Indian J Pediatr       Date:  2012-07-06       Impact factor: 1.967

6.  Enzyme linked immuno-spot; a useful tool in the search for elusive immune markers in common pediatric immunological diseases.

Authors:  Maria Faresjö
Journal:  Cells       Date:  2012-05-29       Impact factor: 6.600

Review 7.  Long term follow up of celiac disease-is atherosclerosis a problem?

Authors:  Anna Rybak; Bożena Cukrowska; Jerzy Socha; Piotr Socha
Journal:  Nutrients       Date:  2014-07-21       Impact factor: 5.717

8.  Serum cytokine pattern in young children with screening detected coeliac disease.

Authors:  S Björck; S R Lindehammer; M Fex; D Agardh
Journal:  Clin Exp Immunol       Date:  2015-02       Impact factor: 4.330

9.  Suppressed immune profile in children with combined type 1 diabetes and celiac disease.

Authors:  A Tompa; K Åkesson; S Karlsson; M Faresjö
Journal:  Clin Exp Immunol       Date:  2020-06-14       Impact factor: 4.330

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.